Page last updated: 2024-09-03

imatinib mesylate and Niemann-Pick Disease, Type C

imatinib mesylate has been researched along with Niemann-Pick Disease, Type C in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvarez, AR; Amigo, J; Bronfman, FC; Cancino, GI; Castro, J; Klein, A; Mosqueira, M; Vargas, LM; YĆ©venes, LF; Zanlungo, S1

Other Studies

1 other study(ies) available for imatinib mesylate and Niemann-Pick Disease, Type C

ArticleYear
Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:10

    Topics: Animals; Apoptosis; Benzamides; Cell Survival; Cerebellar Cortex; Disease Models, Animal; DNA-Binding Proteins; Gene Expression; Imatinib Mesylate; Intracellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Motor Activity; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Nuclear Proteins; Piperazines; Proteins; Proto-Oncogene Proteins c-abl; Purkinje Cells; Pyrimidines; RNA, Messenger; Tumor Protein p73; Tumor Suppressor Proteins

2008